874
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Design, synthesis and pharmacological evaluation of conformationally restricted N-arylsulfonyl-3-aminoalkoxy indoles as a potential 5-HT6 receptor ligands

, , , , , , & show all
Pages 341-349 | Received 04 May 2010, Accepted 19 Jul 2010, Published online: 27 Apr 2011

References

  • Monsma FJ Jr, Shen Y, Ward RP, Hamblin MW, Sibley DR. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 1993; 43:320–327.
  • Ruat M, Traiffort E, Arrang JM, Tardivel-Lacombe J, Diaz J, Leurs R, Schwartz JC. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun 1993; 193:268–276.
  • Kohen R, Metcalf MA, Khan N, Druck T, Huebner K, Lachowicz JE, Meltzer HY, Sibley DR, Roth BL, Hamblin MW. Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor. J Neurochem 1996; 66:47–56.
  • Kohen R, Fashingbauer LA, Heidmann DE, Guthrie CR, Hamblin MW. Cloning of the mouse 5-HT6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop. Brain Res Mol Brain Res 2001; 90:110–117.
  • Liu KG, Robichaud AJ. 5-HT6 antagonists as potential treatment for cognitive dysfunction. Drug Dev Res 2009; 70:145–168.
  • Werner JG, Cornelis JV. The serotonin 5-HT6 receptor: a viable drug target for treating cognitive deficits in Alzheimer’s disease. Exp Rev Neurother 2009; 9:1073–1085.
  • Witty D, Mahmood A, Tsu TC. Advances in the design of 5-HT6 receptor ligands with therapeutic potential. Prog Med Chem 2009; 48:163–224.
  • Gerard R, Herve S. 5-HT6 receptor antagonists as potential therapeutics for cognitive impairment. Curr Top in Med Chem 2010; 10:207–221.
  • Zvartau-Hind M. 11th Int. Conf. on Alz. Dis. Rel. Dis. (July 26–31, Chicago), 2008; Abst 03–04–06.
  • Mather-Edwards G. 11th Int. Conf. on Alz. Dis. Rel. Dis. (July 26–31, Chicago), 2008; Abst P4–341.
  • Lesem M. 11th Int. Cong. of Schiz. Res. (March 28–April 1, Colorado Springs), 2007.
  • Nirogi R, Kambhampati R, Shinde A, Kandikere V, Mudigonda K, Bhyrapuneni G, Jayarajan P, Abraham R, Mulla SM, Jasti V. 12th Int. Conf. on Alz. Dis. Rel. Dis. (July 11–16, Vienna), 2009; Abst P1–25.
  • Maher-Edwards G, Zvartau-Hind M, Hunter AJ, Michael G, Gillian H, Gemma J, Maria D, Pauline W. Double-Blind, Controlled Phase II Study of a 5-HT6 receptor antagonist, SB-742457, in Alzheimer’s Disease. Curr Alz Res 2010; 7:374–385.
  • Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK. 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors. J Med Chem 2000; 43:1011–1018.
  • Cole DC, Mahwah MA. Sulfonyltetrahydro-3H-benzo(E)indole-8-amine compounds as 5-HT6 ligands. US 2005/0101596.
  • Liu KG, Lo JR, Comery TA, Zhang GM, Zhang JY, Kowal DM, Smith DL, Di L, Kerns EH, Schechter LE, Robichaud AJ. A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligands. Bioorg Med Chem Lett 2008; 18:3929–3931.
  • Ramakrishna VSN, Kambhampati RS, Shirsath VS, Jasti V. Novel indeno[2,1A] indanes and isoindolo[2,1-A]indoles WO 2005/066184.
  • Jasti V, Ramakrishna VSN, Kambhampati RS, Battula SR, Veerareddy A, Rao VSVV. Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them. WO 2004/000849.
  • Ramakrishna VSN, Kambhampati RS, Shirsath VS, Jasti V. Benzothiazino indoles. WO 2005/005439.
  • Ramakrishna VSN, Kambhampati RS, Shirsath VS, Jasti V. Tetracyclic 3-substituted indoles having serotonin receptor affinity. WO 2004/055026.
  • Woolley ML, Bentley JC, Sleight AJ, Marsden CA, Fone KC. A role for 5-ht6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 2001; 41:210–219.
  • Assays performed at Novascreen Biosciences Corporation, Hanover, Maryland, USA.
  • Monsma FJ Jr., Shen Y, Ward RP, Hamblin MW, Sibley DR. Molecular cloning and expression of novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol Pharmacol 1993; 43:320–327.
  • Conway SC, Gribble WG, Synthesis of 1-(Phenylsulfonyl)Indol-3-yl Trifluoromethanesulfonate. Heterocycles. 1990; 30:627–633.
  • Su HCF, Tsou KC. Synthesis of bromo-substituted indoxyl esters for cytochemical demonstration of esterase activity. J Am Chem Soc 1960; 82:1187–1189.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.